Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

NCT06861777 is registered in ClinicalTrials.gov with YIN LI as lead sponsor.

NCT NCT06861777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06861777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Lead sponsor
YIN LI
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
May 31, 2031
Enrollment
474 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal squamous cell carcinoma (escc)